SYNTHORX - Trademark Details
Status: 733 - Fourth Extension - Granted
Image for trademark with serial number 88505851
Serial Number
88505851
Word Mark
SYNTHORX
Status
733 - Fourth Extension - Granted
Status Date
2021-11-10
Filing Date
2019-07-09
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
260129, 270305 - Helixes. Representations of objects forming letters or numerals, including punctuation.
Published for Opposition Date
2019-11-05
Attorney Name
Karen Lim
Law Office Assigned Location Code
N50
Employee Name
LAMONT, JOHN CHRISTOPH
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of the term "SYNTHORX" in stylized font with a double helix design within the "O" in "SYNTHORX".
Goods and Services
protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, pharmaceutical preparations for use in immunology, oncology including immuno-oncology, cardiovascular and metabolic diseases, and infectious diseases; protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases; protein therapeutics namely, pharmaceutical preparations for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer and autoimmune disorders, cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, coagulation factors, lipid binding proteins, protein factors for manufacturing of adoptive cell therapy products, anti-infectives, pain killers, and tissue repair factors; non-natural protein modifications for use in connection with a variety of therapeutic areas, namely, protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics
Goods and Services
medical research; scientific research in the field of DNA; pharmaceutical research and development; laboratory research services in the field of pharmaceuticals; pharmaceutical research in the field of protein therapeutics; pharmaceutical research in the fields of immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, geriatrics, genetics and phenomics, pathology and forensics, proteomics, and veterinary medicine and diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using a semi-synthetic organism for use in drug development; pharmaceutical research, namely, research relating to synthetic proteins incorporating one or more non-natural amino acids for improving pharmacological properties; pharmaceutical research, namely, research relating to synthetic proteins for use in connection with a wide variety of therapeutic agents
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-07-17
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-07-17
Primary Code
042
Current Trademark Owners
Party Name
Synthorx, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Synthorx, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Synthorx, Inc.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Karen Lim
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
1
Reference Number
A0098200
Original Filing Date USPTO
2020-07-10
International Registration Number
1562572
International Registration Date
2020-07-10
International Status Code
480
International Renewal Date
2030-07-10
Madrid History Events
DateCodeDescription
2020-07-23MCERTMANUALLY CERTIFIED
2020-07-23APPSTIR CERTIFIED AND SENT TO IB
2020-10-21IRRCVIRREGULARITY RESPONSE RECEIVED FROM APPLICANT
2020-11-26CREATAPPLICATION FOR IR REGISTERED BY IB
2020-07-10NEWAPNEW APPLICATION FOR IR RECEIVED
2020-10-26IRRACRESPONSE TO IRREGULARITY REVIEWED AND ACCEPTED
2020-10-26IRSNTIRREGULARITY RESPONSE SENT TO IB
2020-08-10IRREGIRREGULARITY NOTICE RECEIVED FROM IB
Trademark Events
Event DateEvent Description
2019-07-12NEW APPLICATION ENTERED IN TRAM
2019-07-17NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-07-18NOTICE OF DESIGN SEARCH CODE E-MAILED
2019-09-25ASSIGNED TO EXAMINER
2019-09-26APPROVED FOR PUB - PRINCIPAL REGISTER
2019-10-16NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2019-11-05PUBLISHED FOR OPPOSITION
2019-11-05OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2019-12-31NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2020-02-07TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-02-07ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-02-10TEAS CHANGE OF OWNER ADDRESS RECEIVED
2020-02-10APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2020-06-09TEAS EXTENSION RECEIVED
2020-06-09EXTENSION 1 FILED
2020-06-09EXTENSION 1 GRANTED
2020-06-11NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-11-03TEAS EXTENSION RECEIVED
2020-11-03EXTENSION 2 FILED
2020-11-03EXTENSION 2 GRANTED
2020-11-05NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-05-05TEAS EXTENSION RECEIVED
2021-05-05EXTENSION 3 FILED
2021-05-05EXTENSION 3 GRANTED
2021-05-07NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-11-10TEAS EXTENSION RECEIVED
2021-11-10EXTENSION 4 FILED
2021-11-10EXTENSION 4 GRANTED
2021-11-12NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED